$59.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
Updated COA's
Secure Shipping Guaranteed
Verified for Purity
$59.99
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
Looking for Cardarine for sale with unmatched consistency and quality? Our Liquid GW-501516 is produced in a controlled lab environment with rigorous quality assurance, designed solely for research purposes.
The product is manufactured under the technical guidance of experienced chemists to ensure quality and consistency. Each batch undergoes purity testing and is precisely measured to ensure reproducible results in experimental models.
Please note that reputable pharmaceutical companies do not produce Cardarine for consumer use; this product is intended solely for research.
Cardarine, also known as GW-501516, is a small-molecule metabolic modulator that displays high affinity for peroxisome proliferator-activated receptors, specifically the delta subtype (PPARδ). Although often mistakenly classified as a selective androgen receptor modulator (SARM), Cardarine does not target androgen receptors and functions through a distinct mechanism.
Initially developed by pharmaceutical companies for potential treatments of metabolic and muscle-wasting disorders, Cardarine drew research interest due to its effects on skeletal muscle cells, energy expenditure, and fatty acid metabolism. Early clinical trials and animal research suggested positive effects and potential benefits for endurance and lean muscle development. Still, long-term safety concerns, including rapid cancer development in several organs in rodents, halted human clinical development programs.
If you want to buy Cardarine, always choose reputable, lab-tested sources to ensure you receive a high-quality and authentic product.
Cardarine binds to and activates PPARδ receptors, regulating the transcription of genes involved in lipid catabolism, fatty acid oxidation, glucose uptake, mitochondrial function, and energy metabolism. Among the downstream targets are proteins involved in fatty acid transport and oxidation, mitochondrial uncoupling, and energy expenditure. Activation of peroxisome proliferator-activated receptor delta shifts skeletal muscle toward greater use of fatty acids as a primary energy substrate, enhancing oxidative capacity and metabolic efficiency.
Studies in animal models have shown increased energy uncoupling, mitochondrial biogenesis, and improved endurance-related pathways—key reasons why endurance athletes and performance researchers have explored its effects. Cardarine has also shown potential in stabilizing blood cholesterol levels and influencing blood flow and blood pressure markers in preclinical settings.
Cardarine (GW-501516) is a selective PPARδ agonist studied for its effects on:
These applications reflect preclinical research only. Cardarine is not approved as a drug, dietary supplement, or performance enhancer.
For researchers pursuing similar metabolic, endurance, or fat oxidation pathways, there are legal alternatives that may offer comparable research endpoints without the legal or regulatory concerns associated with GW-501516. Any use should follow appropriate laboratory protocols and structured research methodologies to ensure safety and reproducibility.
| Chemical Name | GW-501516 |
| Classification | PPARδ Agonist (Metabolic Modulator) |
| CAS Number | 317318-70-0 |
| Molecular Formula | C₂₁H₁₈F₃NO₃S₂ |
| Relative Molecular Mass | ~453.5 g/mol |
| Reported Half-Life | ~16–24 hours (model-dependent) |
| Forms Offered | Liquid and/or Powder Form (research grade; batch COA provided) |
| Intended Use | For Laboratory Research Only; Not for Human or Veterinary Use |
Cardarine (also known as GW-501516) exhibits a high affinity for peroxisome proliferator-activated receptors, specifically the δ subtype (PPARδ).
Note: Cardarine is available for research purposes in both liquid and powder form.
This liquid Cardarine preparation is intended solely for laboratory research purposes and is not approved by the FDA for human consumption. Cardarine is not a dietary supplement or sports supplement.
Preclinical animal research initially showed promise for Cardarine in areas such as lipid metabolism, endurance, and fat oxidation, but human clinical trials were discontinued due to safety concerns. Long-term rodent studies revealed increased rates of cancer development in multiple organs, leading to the termination of development programs. Additional concerns have included potential liver toxicity, cardiovascular effects, and unknown impacts on hormone regulation.
Research involving Cardarine should always follow controlled experimental protocols, including precise dosing and appropriate safety measures, to minimize potential health risks. Excessive exposure to GW-501516 has been associated with serious adverse outcomes, including organ toxicity and carcinogenicity in animal studies. There is also a risk of misuse and substance abuse, which can lead to legal consequences and health complications.
Cardarine is not approved for human use, and its effects on parameters such as heart health, blood pressure, and testosterone levels require further research. Any use outside of legitimate research settings is strongly discouraged and may pose significant health and legal risks.
Cardarine underwent early human clinical trials, which were halted in 2007 after long-term animal studies revealed rapid tumor development in several organs, including the liver, stomach, and thyroid. These findings raised significant health risks, including concerns of liver toxicity and carcinogenicity. Preliminary human studies suggested possible improvements in lipid profiles and insulin resistance, but the short duration of these trials limits conclusions.
The World Anti-Doping Agency (WADA) has banned Cardarine due to its performance-enhancing effects. Athletes caught using the compound have tested positive in professional sports doping controls. Legal restrictions vary by region; some countries classify GW-501516 as a controlled substance, while others regulate it under research chemical frameworks—the marketing of Cardarine products as dietary supplements is illegal in the U.S.
Non-clinical data and case reports highlight several safety concerns:
Because of these findings, regulatory agencies emphasize caution and strict research-only use. Long-term human safety data remain unknown.
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., … & Sakai, J. (2003). Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences, 100(26), 15924-15929.
Cardarine (GW-501516) is a PPARδ agonist researched for its impact on energy regulation, fat metabolism, and endurance in preclinical studies.
No. Cardarine is a PPARδ agonist, not a selective androgen receptor modulator. It works by activating peroxisome proliferator activated receptors involved in fatty acid metabolism, not androgen receptors.
Store in a cool, dry, UV-protected location according to laboratory SOPs. Follow handling and disposal guidelines for research chemicals.
No. Cardarine is not FDA-approved, not a dietary supplement, and not for human consumption. Clinical trials were discontinued after serious health risks were identified.
This product is not for human consumption. It is intended solely for laboratory research.
Yes. We provide fast shipping and secure packaging to maintain integrity during transit.
Due to its performance enhancement potential, the World Anti-Doping Agency prohibits its use in professional sports. Athletes tested positive for GW-501516 have faced sanctions.
No. We do not provide dosing, post cycle therapy, or supplement guidance. Cardarine is supplied strictly for research purposes and we adhere to all FDA regulations.
The research chemical marketplace can contain counterfeit or substandard products. ResearchChemical.com prioritizes authenticity and safety:
Third-party testing: Each batch undergoes independent analysis, with a Certificate of Analysis (COA) verifying identity, purity, and concentration.
Controlled packaging: UV-resistant, tamper-evident containers protect product integrity.
Transparent specifications: Clear labeling, documentation, and batch tracking support reproducibility.
Secure fulfillment: Discreet packaging and secure checkout reduce risks of tampering or counterfeit substitution.
With thousands of satisfied researchers, Research Chemical has built a reputation as a trusted leader in the SARMs and peptide market. Our products are:
Whether you’re ordering GW501516, MK677, or other compounds, our quality control and consistency set us apart
Looking for more SARMs? Explore MK 677 Ibutamoren, Ostarine, and LGD-4033. Need peptides? Check out our BPC-157 and TB-500 for research use only.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Cardarine binds to and activates PPARδ receptors, regulating the transcription of genes involved in lipid catabolism, fatty acid oxidation, glucose uptake, mitochondrial function, and energy metabolism. Among the downstream targets are proteins involved in fatty acid transport and oxidation, mitochondrial uncoupling, and energy expenditure. Activation of peroxisome proliferator-activated receptor delta shifts skeletal muscle toward greater use of fatty acids as a primary energy substrate, enhancing oxidative capacity and metabolic efficiency.
Studies in animal models have shown increased energy uncoupling, mitochondrial biogenesis, and improved endurance-related pathways—key reasons why endurance athletes and performance researchers have explored its effects. Cardarine has also shown potential in stabilizing blood cholesterol levels and influencing blood flow and blood pressure markers in preclinical settings.
| Chemical Name | GW-501516 |
| Classification | PPARδ Agonist (Metabolic Modulator) |
| CAS Number | 317318-70-0 |
| Molecular Formula | C₂₁H₁₈F₃NO₃S₂ |
| Relative Molecular Mass | ~453.5 g/mol |
| Reported Half-Life | ~16–24 hours (model-dependent) |
| Forms Offered | Liquid and/or Powder Form (research grade; batch COA provided) |
| Intended Use | For Laboratory Research Only; Not for Human or Veterinary Use |
Cardarine (also known as GW-501516) exhibits a high affinity for peroxisome proliferator-activated receptors, specifically the δ subtype (PPARδ).
Note: Cardarine is available for research purposes in both liquid and powder form.
This liquid Cardarine preparation is intended solely for laboratory research purposes and is not approved by the FDA for human consumption. Cardarine is not a dietary supplement or sports supplement.
Preclinical animal research initially showed promise for Cardarine in areas such as lipid metabolism, endurance, and fat oxidation, but human clinical trials were discontinued due to safety concerns. Long-term rodent studies revealed increased rates of cancer development in multiple organs, leading to the termination of development programs. Additional concerns have included potential liver toxicity, cardiovascular effects, and unknown impacts on hormone regulation.
Research involving Cardarine should always follow controlled experimental protocols, including precise dosing and appropriate safety measures, to minimize potential health risks. Excessive exposure to GW-501516 has been associated with serious adverse outcomes, including organ toxicity and carcinogenicity in animal studies. There is also a risk of misuse and substance abuse, which can lead to legal consequences and health complications.
Cardarine is not approved for human use, and its effects on parameters such as heart health, blood pressure, and testosterone levels require further research. Any use outside of legitimate research settings is strongly discouraged and may pose significant health and legal risks.
Cardarine underwent early human clinical trials, which were halted in 2007 after long-term animal studies revealed rapid tumor development in several organs, including the liver, stomach, and thyroid. These findings raised significant health risks, including concerns of liver toxicity and carcinogenicity. Preliminary human studies suggested possible improvements in lipid profiles and insulin resistance, but the short duration of these trials limits conclusions.
The World Anti-Doping Agency (WADA) has banned Cardarine due to its performance-enhancing effects. Athletes caught using the compound have tested positive in professional sports doping controls. Legal restrictions vary by region; some countries classify GW-501516 as a controlled substance, while others regulate it under research chemical frameworks—the marketing of Cardarine products as dietary supplements is illegal in the U.S.
Non-clinical data and case reports highlight several safety concerns:
Because of these findings, regulatory agencies emphasize caution and strict research-only use. Long-term human safety data remain unknown.
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., … & Sakai, J. (2003). Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences, 100(26), 15924-15929.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.
